These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11013012)
21. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370 [TBL] [Abstract][Full Text] [Related]
22. C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry. Werfel T; Oppermann M; Begemann G; Götze O; Zwirner J Arch Dermatol Res; 1997 Jan; 289(2):83-6. PubMed ID: 9049041 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59. Mizuno M; Nishikawa K; Morgan BP; Matsuo S Clin Exp Immunol; 2000 Feb; 119(2):368-75. PubMed ID: 10632677 [TBL] [Abstract][Full Text] [Related]
24. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. Wetsel RA Immunol Lett; 1995 Jan; 44(2-3):183-7. PubMed ID: 7797249 [TBL] [Abstract][Full Text] [Related]
25. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437 [TBL] [Abstract][Full Text] [Related]
26. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation. Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263 [TBL] [Abstract][Full Text] [Related]
27. Expression and induction of anaphylatoxin C5a receptors in the rat liver. Schlaf G; Schmitz M; Rothermel E; Jungermann K; Schieferdecker HL; Götze O Histol Histopathol; 2003 Jan; 18(1):299-308. PubMed ID: 12507307 [TBL] [Abstract][Full Text] [Related]
28. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis. Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320 [TBL] [Abstract][Full Text] [Related]
29. Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. Farzan M; Schnitzler CE; Vasilieva N; Leung D; Kuhn J; Gerard C; Gerard NP; Choe H J Exp Med; 2001 May; 193(9):1059-66. PubMed ID: 11342590 [TBL] [Abstract][Full Text] [Related]
30. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252 [TBL] [Abstract][Full Text] [Related]
31. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus. Monk PN; Barker MD; Partridge LJ; Pease JE J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471 [TBL] [Abstract][Full Text] [Related]
32. Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease. Farkas I; Takahashi M; Fukuda A; Yamamoto N; Akatsu H; Baranyi L; Tateyama H; Yamamoto T; Okada N; Okada H J Immunol; 2003 Jun; 170(11):5764-71. PubMed ID: 12759460 [TBL] [Abstract][Full Text] [Related]
33. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). Cain SA; Monk PN J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063 [TBL] [Abstract][Full Text] [Related]
35. cDNA cloning and characterization of rat C5a anaphylatoxin receptor. Akatsu H; Miwa T; Sakurada C; Fukuoka Y; Ember JA; Yamamoto T; Hugli TE; Okada H Microbiol Immunol; 1997; 41(7):575-80. PubMed ID: 9272704 [TBL] [Abstract][Full Text] [Related]
36. Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain. Naik N; Giannini E; Brouchon L; Boulay F J Cell Sci; 1997 Oct; 110 ( Pt 19)():2381-90. PubMed ID: 9410877 [TBL] [Abstract][Full Text] [Related]
37. IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines. Burg M; Martin U; Rheinheimer C; Köhl J; Bautsch W; Böttger EC; Klos A J Immunol; 1995 Nov; 155(9):4419-26. PubMed ID: 7594603 [TBL] [Abstract][Full Text] [Related]
38. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. Floreani AA; Heires AJ; Welniak LA; Miller-Lindholm A; Clark-Pierce L; Rennard SI; Morgan EL; Sanderson SD J Immunol; 1998 May; 160(10):5073-81. PubMed ID: 9590258 [TBL] [Abstract][Full Text] [Related]
39. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Zwirner J; Fayyazi A; Götze O Mol Immunol; 1999; 36(13-14):877-84. PubMed ID: 10698342 [TBL] [Abstract][Full Text] [Related]
40. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells. Tardif M; Mery L; Brouchon L; Boulay F J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]